Male fertility potential alteration in rheumatic diseases: a systematic review

Abstract

Background Improved targeted therapies for rheumatic diseases were developed recently resulting in a better prognosis for affected patients. Nowadays, patients are living longer and with improved quality of life, including fertility potential. These patients are affected by impaired reproductive function and the causes are often multifactorial related to particularities of each disease. This review highlights how rheumatic diseases and their management affect testicular function and male fertility.Materials and Methods A systematic review of literature of all published data after 1970 was conducted. Data was collected about fertility abnormalities in male patients with systemic lupus erythematosus, rheumatoid arthritis, dermatomyositis, ankylosing spondylitis, Behçet disease and gout. Two independent researchers carried out the search in online databases.Results A total of 19 articles were included addressing the following diseases: 7 systemic lupus erythematosus, 6 Behçet disease, 4 ankylosing spondylitis, 2 rheumatoid arthritis, 2 dermatomyositis and one gout. Systemic lupus erythematosus clearly affects gonadal function impairing spermatogenesis mainly due to antisperm antibodies and cyclophosphamide therapy. Behçet disease, gout and ankylosing spondylitis patients, including those under anti-TNF therapy in the latter disease, do not seem to have reduced fertility whereas in dermatomyositis, the fertility potential is hampered by disease activity and by alkylating agents. Data regarding rheumatoid arthritis is scarce, gonadal dysfunction observed as consequence of disease activity and antisperm antibodies.Conclusions Reduced fertility potential is not uncommon. Its frequency and severity vary among the different rheumatic diseases. Permanent infertility is rare and often associated with alkylating agent therapy.

Epidemiology and management practices for childhood-onset systemic lupus erythematosus patients: a survey in Latin America

“…Female and male strategies to prevent infertility in cSLE patients under IVCYC use were rarely reported by LAPR, probably due to the high financial cost of these medications [36][37][38]. Well-established transition programs are still a challenge in LA clinical practice.…”

Plasmapheresis in Treatment of Myasthenia Gravis

“…Prospectively, after rituximab treatment, neutropenia with pneumonia and other infectious complications may develop in up to 17% [33,34]. There are reports about development of male infertility due to either gonadal dysfunction or antisperm autoantibodies production [35]. In addition, as noted above, removal of B-cells is not always accompanied by decrease in the autoantibodies reproduction [10].…”

Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence

“…In women, effective disease control improves pregnancy outcomes (4) with the BSR guidelines identifying rheumatic drugs which are safe to continue during pregnancy and breastfeeding. In men, there is some evidence identifying a relationship between rheumatic disease activity and fertility (5)(6)(7). Active inflammatory disease may negatively affect sperm quality hence fertility (8)(9)(10).…”